About Emily England

This author has not yet filled in any details.
So far Emily England has created 29 blog entries.

10,000th Australian patient accrued by ground-breaking cancer trials collaborative

By |2020-10-20T01:33:34+00:00October 20th, 2020|General|

In a major milestone for Australian cancer patients, the not-for-profit, member-based organisation, Cancer Trials Australia (CTA), has recently marked the recruitment of the 10,000th oncology patient to clinical trials [...]

CTA CEO discusses key considerations for Chinese biotechs considering conducting clinical trials in Australia

By |2019-11-15T03:33:55+00:00November 15th, 2019|General|

Cancer Trials Australia’s CEO, Dr. Kurt Lackovic, was a panelist at the 12th annual ‘China Trials – Clinical Development Leaders’ summit’ in Shanghai this week.  Other panelists included Jayden [...]

CTA announces partnership to drive Teletrials forward at Victorian study sites

By |2019-11-19T04:13:17+00:00November 11th, 2019|General|

Cancer Trials Australia (CTA) is pleased to announce a new project, to be delivered with the Victorian Comprehensive Cancer Centre (VCCC), providing Victorian sites with an exciting opportunity to [...]

CTA CEO presents at 3rd Annual Accelerating Clinical Trials in Asia conference

By |2019-11-11T04:18:16+00:00September 26th, 2019|General|

By 2021, the global market for clinical trials is anticipated to grow to $60Bn, a 75% increase over 2015. The largest contributor to this huge growth is the Asia-Pacific region.Cancer [...]

Coordinated Electronic Document Management for Victorian study sites

By |2019-08-20T13:42:14+00:00November 22nd, 2018|General|

CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]

Fast, Quality Clinical Trials for Less: Let Melbourne, Australia be Your Partner

By |2018-04-30T03:51:56+00:00April 30th, 2018|General|

Cancer Trials Australia's CEO, Dr Kurt Lackovic, was recently invited to speak at an international webinar showcasing Melbourne as a premier location for the conduct of Phase 1 clinical trials. Aimed primarily at international [...]

Go to Top